Navigation Links
Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate
Date:5/11/2009

FRANKFORT, Mich., May 11 /PRNewswire/ -- The following is being released today by Howard E. Greene, Jr.

To my fellow shareholders:

As the founding CEO of Amylin and a board member for almost 22 years, I want you to know how I plan to vote at our annual meeting.

In my opinion Amylin's talented employee team has created one of the best product and technology platforms in the diabetes and obesity area. But, shareholders have suffered because sales results have not reflected the commercial potential of that platform.

I commend our present management team, under Dan Bradbury's leadership, for recognizing that they need to achieve a more effective working relationship with Lilly, and that they must design a more innovative strategy for convincing primary care physicians that Amylin's injectible medicines are their best treatment option for patients with diabetes.

Our board of directors will play a strategic role in meeting these challenges. I believe management will have more freedom to think outside of the box if we replace the directors most directly involved in crafting the disappointing commercialization strategy.

Also, with the departures of Ginger Graham and me, the Amylin board loses more than 60% of its stock ownership. I think our investors would be well served by adding directors who directly represent large shareholdings.

So, I have decided to vote for the slate proposed by Eastbourne, including the Icahn nominees.

Respectfully,

Howard E. Greene, Jr., Co-Founder of Amylin


'/>"/>
SOURCE Howard E. Greene, Jr.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017  Applied BioMath ( ... modeling to drug research and development, today ... Zymeworks Inc. for quantitative systems pharmacology (QSP) ... for the treatment of cancer. ... for GLP toxicology studies and first-in-human dose ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... that it is exhibiting in booth 513 at the Association of Community Cancer ... Downtown Hotel, March 29-31. , CANCERSCAPE unites key stakeholders from leading national ...
(Date:3/29/2017)... March 29, 2017 /PRNewswire/ - The University of Missouri ... a business of Sterigenics International, and General Atomics (GA), ... submitted to the U.S. Nuclear Regulatory Commission (NRC). This ... of molybdenum-99 (Mo-99). Once operational, production from this facility ... demand for Mo-99, which currently must be imported from ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... for the Advancement of Science (AAAS), the world's largest general scientific society ... its high-impact scholarly collection across its cross-platform reference management system. , All ...
Breaking Biology Technology:
(Date:2/28/2017)... February 28, 2017 News solutions for biometrics, ... ... from 14 to 16 March, Materna will present its ... how seamless travel is a real benefit for passengers. To ... to their passenger touch point solutions to take passengers through the ...
(Date:2/22/2017)... Feb. 22, 2017 With the biometrics ... Research identifies four technologies that innovative and agile ... significant share in the changing competitive landscape: multifactor ... authentication.   "Companies can no longer ... security," says Dimitrios Pavlakis , Industry Analyst ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):